ASCO® 2023 Insights: "Phase 3 CONTACT-03 Study - Efficacy & Safety of Atezo + Cabo vs. Cabo Alone After Progression With Prior ICI Treatment in mRCC"
By
ecancer
FEATURING
Toni Choueiri
By
ecancer
FEATURING
Toni Choueiri
Login to view comments.
Click here to Login